Total Payments
$3,992
2024 Payments
$108.80
Companies
27
Transactions
239
Medicare Patients
1,058
Medicare Billing
$118,919
Payment Breakdown by Category
Food & Beverage$3,806 (95.3%)
Education$167.68 (4.2%)
Consulting$18.66 (0.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,806 | 235 | 95.3% |
| Education | $167.68 | 3 | 4.2% |
| Consulting Fee | $18.66 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $1,279 | 78 | $0 (2023) |
| PFIZER INC. | $590.63 | 49 | $0 (2023) |
| Janssen Biotech, Inc. | $498.33 | 24 | $0 (2023) |
| Gilead Sciences, Inc. | $342.49 | 10 | $0 (2024) |
| Allergan Inc. | $168.62 | 16 | $0 (2018) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $121.79 | 9 | $0 (2019) |
| Shire North American Group Inc | $118.59 | 8 | $0 (2018) |
| Janssen Scientific Affairs, LLC | $113.99 | 1 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $106.27 | 7 | $0 (2023) |
| Synergy Pharmaceuticals Inc | $95.22 | 5 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $108.80 | 1 | Gilead Sciences, Inc. ($108.80) |
| 2023 | $565.69 | 23 | AbbVie Inc. ($244.88) |
| 2022 | $655.19 | 38 | ABBVIE INC. ($185.43) |
| 2021 | $421.56 | 29 | AbbVie Inc. ($169.85) |
| 2020 | $272.34 | 13 | Janssen Biotech, Inc. ($146.50) |
| 2019 | $578.87 | 44 | PFIZER INC. ($156.67) |
| 2018 | $918.11 | 57 | AbbVie, Inc. ($356.55) |
| 2017 | $471.79 | 34 | AbbVie, Inc. ($134.20) |
All Payment Transactions
239 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/10/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $108.80 | General |
| Category: HCV | ||||||
| 06/14/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: IMMUNOLOGY | ||||||
| 05/30/2023 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $3.61 | General |
| Category: VIROLOGY | ||||||
| 05/23/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.47 | General |
| 05/17/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/03/2023 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: VIROLOGY | ||||||
| 04/27/2023 | AbbVie Inc. | LINZESS (Drug), CREON, VIBERZI | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/26/2023 | AbbVie Inc. | LINZESS (Drug), CREON, VIBERZI | Food and Beverage | In-kind items and services | $1.25 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/25/2023 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/18/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Immunology | ||||||
| 04/12/2023 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 04/05/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: IMMUNOLOGY | ||||||
| 04/04/2023 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $13.69 | General |
| 03/30/2023 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: VIROLOGY | ||||||
| 03/29/2023 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $109.92 | General |
| Category: HCV | ||||||
| 03/29/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.67 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/28/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $117.35 | General |
| Category: IMMUNOLOGY | ||||||
| 03/15/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.89 | General |
| 03/09/2023 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 03/07/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: IMMUNOLOGY | ||||||
| 02/22/2023 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 01/31/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: INTERNAL MEDICINE | ||||||
| 01/19/2023 | Braintree Laboratories, Inc. | SUTAB (Drug) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: GI COLON PREP | ||||||
| 01/04/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: IMMUNOLOGY | ||||||
| 12/01/2022 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 88 | 88 | $53,830 | $11,114 |
| 2022 | 8 | 289 | 295 | $145,625 | $33,766 |
| 2021 | 11 | 376 | 383 | $224,725 | $48,524 |
| 2020 | 9 | 305 | 316 | $96,020 | $25,515 |
Total Patients
1,058
Total Services
1,082
Medicare Billing
$118,919
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 39 | 39 | $24,740 | $7,040 | 28.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 38 | 38 | $20,695 | $2,513 | 12.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 11 | 11 | $8,395 | $1,562 | 18.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 81 | 82 | $52,005 | $15,116 | 29.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 74 | 76 | $39,765 | $4,880 | 12.3% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 24 | 24 | $11,040 | $4,173 | 37.8% |
| 43237 | Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope through mouth | Facility | 2022 | 21 | 21 | $18,250 | $2,523 | 13.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 41 | 44 | $5,280 | $2,505 | 47.4% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 15 | 15 | $7,850 | $1,927 | 24.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 15 | 15 | $9,005 | $1,445 | 16.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 18 | 18 | $2,430 | $1,198 | 49.3% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 82 | 82 | $52,330 | $15,721 | 30.0% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 113 | 114 | $58,995 | $7,717 | 13.1% |
| 43274 | Insertion of stent into pancreatic or bile duct using a flexible endoscope via mouth | Facility | 2021 | 13 | 14 | $12,650 | $5,103 | 40.3% |
| 45378 | Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk | Facility | 2021 | 31 | 32 | $15,135 | $4,551 | 30.1% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 39 | 39 | $23,285 | $4,336 | 18.6% |
| 43264 | Removal of stone or debris from bile or pancreatic duct using a flexible endoscope via mouth | Facility | 2021 | 15 | 15 | $11,970 | $2,776 | 23.2% |
| 43237 | Ultrasound examination of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 13 | 14 | $11,250 | $1,982 | 17.6% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2021 | 11 | 11 | $5,000 | $1,866 | 37.3% |
| 43262 | Incision of pancreatic outlet using a flexible endoscope via mouth | Facility | 2021 | 11 | 13 | $10,420 | $1,625 | 15.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 35 | 36 | $4,320 | $1,555 | 36.0% |
| 43249 | Balloon dilation of esophagus, stomach and upper small bowel using a flexible endoscope | Facility | 2021 | 13 | 13 | $19,370 | $1,292 | 6.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope | Facility | 2020 | 42 | 42 | $26,320 | $7,433 | 28.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 93 | 101 | $12,120 | $5,468 | 45.1% |
| 45378 | Diagnostic examination of large bowel using an endoscope | Facility | 2020 | 26 | 26 | $12,175 | $3,486 | 28.6% |
About Dr. Ajoy Roy, M.D
Dr. Ajoy Roy, M.D is a Specialist healthcare provider based in Oswego, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487633400.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ajoy Roy, M.D has received a total of $3,992 in payments from pharmaceutical and medical device companies, with $108.80 received in 2024. These payments were reported across 239 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($3,806).
As a Medicare-enrolled provider, Roy has provided services to 1,058 Medicare beneficiaries, totaling 1,082 services with total Medicare billing of $118,919. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Oswego, NY
- Active Since 01/10/2006
- Last Updated 03/29/2023
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1487633400
Products in Payments
- XELJANZ (Drug) $590.63
- STELARA (Biological) $556.09
- Humira (Biological) $495.35
- HUMIRA (Biological) $253.93
- Epclusa (Drug) $218.72
- SKYRIZI (Biological) $207.95
- LINZESS (Drug) $164.23
- Trulance (Drug) $95.22
- XIFAXAN (Drug) $94.43
- GATTEX (Drug) $82.97
- Entyvio (Biological) $73.26
- VIBERZI (Drug) $72.46
- OCALIVA (Drug) $57.65
- REMICADE (Biological) $56.23
- ELIQUIS (Drug) $55.04
- MAVYRET (Drug) $54.41
- ZEPATIER (Drug) $51.73
- RINVOQ (Biological) $50.84
- ZEPOSIA (Drug) $49.32
- ENTYVIO (Biological) $49.17
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Oswego
Dr. Raj Mahajan, Md, MD
Specialist — Payments: $1,740
Specialist $1,740
Dr. Duk Lee, Md, MD
Specialist
Specialist
Ms. Joanne Wilkins, Otr, OTR
Specialist
Specialist
Deanna Wyatt, Pt, Mhs, PT, MHS
Specialist
Specialist
Lauren Sahm, B.s.ed, B.S.ED
Specialist
Specialist
Jennifer Renzi
Specialist
Specialist